Evolus (EOLS) Net Cash Flow (2017 - 2026)
Evolus (EOLS) posted Net Cash Flow of -$4.0 million for Q1 2026, down 137.47% on a QoQ basis from $10.7 million in Q4 2025, and up 78.96% year-over-year from -$2.2 million in Q1 2025.
Evolus (EOLS) Net Cash Flow (2017 - 2026) Analysis & Trends
Evolus' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- Quarterly Net Cash Flow rose 78.96% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.3 million (up 36.49% YoY) and the FY2025 annual result came in at -$33.4 million, down 235.74% from the prior year.
- Net Cash Flow was -$4.0 million for Q1 2026 at Evolus, down from $10.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $34.2 million in Q1 2024 and bottomed at -$39.5 million in Q1 2022.
- A 5-year average of -$5.6 million and a median of -$6.4 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow sank 196.6% — and 2025, when it surged 403.42%.
- Evolus' Net Cash Flow stood at -$11.7 million in 2022, then jumped by 305.24% to $24.0 million in 2023, then slumped by 91.1% to $2.1 million in 2024, then jumped by 403.42% to $10.7 million in 2025, then plunged by 137.47% to -$4.0 million in 2026.
- Business Quant data shows EOLS's Net Cash Flow at -$4.0 million in Q1 2026, $10.7 million in Q4 2025, and -$18.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Mn |
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Dec 31, 2023 | 23.97 Mn |
| Dec 31, 2023 | 23.97 Mn |